New patient monitoring technology for Guidant
This article was originally published in Clinica
Guidant has acquired privately held Cardiac Intelligence for its patent portfolio in the field of remote wireless patient heart function monitoring. It intends to use the acquired technologies to further its own programme to develop remote and automatic continuous monitoring systems.
You may also be interested in...
The North American trade organization’s new website offers consumers a gateway into the world of fragrance. Providing a “deep dive” into 50 fragrance ingredients, as well as overviews of perfumery, key regulations, and industry safety practices and sustainability efforts, the site extends FCA’s work to engage and inform consumers at a time of growing interest in manufactured scents.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.